Clinical Trial

Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment

Study acronym: HZN-IIT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Describe the progression of inflammatory orbitopathy and the biological progression of patients receiving second-line treatment (immunosuppressants, radiotherapy, or biotherapy).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-05.
Trial Details
NCT Number NCT07117981
Lead Sponsor Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Conditions Basedow Disease
Enrollment 100 participants
Start Date 2024-11-01
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-15